ContextVision AB (publ)

OB:CONTX Stok Raporu

Piyasa değeri: NOK 267.9m

ContextVision Gelecekteki Büyüme

Future kriter kontrolleri 3/6

ContextVision kazanç ve gelirin sırasıyla yıllık 55% ve 2% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 56.1% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 11.9% olacağı tahmin edilmektedir.

Anahtar bilgiler

55.0%

Kazanç büyüme oranı

56.06%

EPS büyüme oranı

Healthcare Services kazanç büyümesi22.7%
Gelir büyüme oranı2.0%
Gelecekteki özkaynak getirisi11.90%
Analist kapsamı

Low

Son güncelleme25 Feb 2026

Gelecekteki son büyüme güncellemeleri

ContextVision AB (publ) (OB:CONTX) Just Reported, And Analysts Assigned A kr5.00 Price Target

Nov 09
ContextVision AB (publ) (OB:CONTX) Just Reported, And Analysts Assigned A kr5.00 Price Target

Earnings Release: Here's Why Analysts Cut Their ContextVision AB (publ) (OB:CONTX) Price Target To kr5.00

Aug 30
Earnings Release: Here's Why Analysts Cut Their ContextVision AB (publ) (OB:CONTX) Price Target To kr5.00

Recent updates

CONTX: Liver Biomarker Collaboration Will Sustain Overvaluation Risk For Ultrasound AI

Analysts have adjusted their price targets on ContextVision to reflect updated assumptions on revenue growth, profit margins and future P/E. The new target is now set at NOK X.XX, compared with the previous NOK Y.YY.

CONTX: Liver Biomarker Collaboration Will Support Fair Outlook For Ultrasound AI

Analysts have adjusted their price target on ContextVision to reflect updated assumptions for the discount rate, revenue growth, profit margin and future P/E. The implied fair value estimate now stands at NOK 3.30.

CONTX: Liver Study And Data Quality Program Will Support Fair Future Prospects

Analysts have adjusted their price target for ContextVision to align with a fair value estimate of NOK 3.30 per share, citing slightly updated assumptions for the discount rate and future P/E ratio, while keeping revenue growth and profit margin expectations broadly unchanged. Valuation Changes Fair Value: NOK 3.30 per share remains unchanged in the updated assessment.

CONTX: Liver Study And Data Quality Program Will Support Balanced Future Prospects

Analysts have reduced their fair value estimate for ContextVision from NOK 4.0 to NOK 3.3, citing updated assumptions for revenue growth, profit margins, future P/E levels, and a slightly higher discount rate. Valuation Changes Fair Value: Reduced from NOK 4.0 to NOK 3.3 per share, a modest cut in the equity valuation used in the model.

CONTX: Liver Study And Data Quality Program Will Support Stronger Future Upside

Analysts have raised their price target for ContextVision, citing slightly stronger assumptions on revenue growth, a marginally lower discount rate and a modestly higher future P/E. They have kept fair value and long-term profit margin expectations broadly in line with prior estimates, which together support a higher NOK-based valuation range.

CONTX: Liver Diagnostics Study Progress Will Support Steady Long Term Outlook

Analysts have adjusted their price target for ContextVision to reflect a fair value of $4.00 and a future P/E of 11.34, citing updated assumptions around discount rates and profitability. What's in the News ContextVision started patient enrollment in its clinical development program for liver disease diagnostics at the University of Washington in Seattle, following Institutional Review Board approval and completion of technical setup (Key Developments).

CONTX: Liver Study Progress And Buybacks Will Support Steady Long Term Outlook

Analysts have nudged their price target on ContextVision slightly higher to reflect small updates to fair value, discount rate, revenue growth, profit margin and future P/E assumptions, while keeping their overall outlook broadly unchanged. What's in the News ContextVision started the clinical phase of its liver disease diagnostics program at the University of Washington in Seattle, with the first patient first visit completed following Institutional Review Board approval and technical validation (Key Developments).

CONTX: Share Buybacks And Stable Assumptions Will Support Steady Long Term Outlook

Analysts have slightly adjusted their price target on ContextVision, reflecting modest tweaks to fair value, discount rate, revenue growth, profit margin and future P/E assumptions. They describe the move as a fine tuning of their outlook rather than a major shift in thesis.

CONTX: Share Buybacks Will Support Per Share Metrics With Stable Long Term Outlook

Analysts have nudged their price target on ContextVision slightly higher to reflect modest improvements in long term fair value and profitability assumptions, now estimating the stock to be worth approximately SEK 4.00 per share versus about SEK 4.00 previously. What's in the News Completed a share buyback tranche, repurchasing 1,440,211 shares (equivalent to 1.86% of outstanding capital) between September 5 and September 30, 2025 (Key Developments) Total consideration for the completed buyback program amounted to NOK 6.42 million under the mandate announced on September 15, 2025 (Key Developments) The conclusion of this buyback tranche reduces the free float and may provide incremental support to per share metrics ahead of future results updates (Key Developments) Valuation Changes Fair Value Estimate is effectively unchanged at around SEK 4.00 per share, reflecting only immaterial rounding differences in the model.

CONTX: Share Buybacks Will Support Capital Efficiency With Balanced Long Term Outlook

Analysts have raised their price target for ContextVision slightly, now valuing the shares at roughly SEK 4.00. This reflects modestly higher confidence in the companys long term earnings power, even as underlying model assumptions have changed only marginally.

CONTX: Share Repurchase Program Will Drive Capital Efficiency And Future Upside

Analysts have adjusted their price target for ContextVision slightly upward to $4.00, citing marginal updates to the discount rate as well as modest changes in growth and profitability assumptions. What's in the News ContextVision completed the repurchase of 1,440,211 shares, representing 1.86% of shares, for NOK 6.42 million between September 5 and September 30, 2025.

More Unpleasant Surprises Could Be In Store For ContextVision AB (publ)'s (OB:CONTX) Shares After Tumbling 25%

Nov 19
More Unpleasant Surprises Could Be In Store For ContextVision AB (publ)'s (OB:CONTX) Shares After Tumbling 25%

CONTX: Share Repurchase Program And Margin Outlook Will Shape Future Performance

Analysts have lowered their price target for ContextVision from $5.00 to $4.00, citing a modest decline in expected revenue growth and a slightly higher discount rate. This adjustment comes despite improved profit margin forecasts.

ContextVision AB (publ) (OB:CONTX) Just Reported, And Analysts Assigned A kr5.00 Price Target

Nov 09
ContextVision AB (publ) (OB:CONTX) Just Reported, And Analysts Assigned A kr5.00 Price Target

We Think That There Are More Issues For ContextVision (OB:CONTX) Than Just Sluggish Earnings

Sep 09
We Think That There Are More Issues For ContextVision (OB:CONTX) Than Just Sluggish Earnings

Earnings Release: Here's Why Analysts Cut Their ContextVision AB (publ) (OB:CONTX) Price Target To kr5.00

Aug 30
Earnings Release: Here's Why Analysts Cut Their ContextVision AB (publ) (OB:CONTX) Price Target To kr5.00

Future Investments In POCUS And Asian Expansion Will Strengthen Market Presence

The downward revision in ContextVision's price target reflects a notable reduction in expected revenue growth, only partially offset by a modest improvement in profit margins, resulting in a lower fair value estimate of NOK5.00. What's in the News ContextVision entered a research partnership with AMRA Medical to advance AI-powered imaging solutions for metabolic dysfunction-associated steatotic liver disease (MASLD).

This Broker Just Slashed Their ContextVision AB (publ) (OB:CONTX) Earnings Forecasts

May 09
This Broker Just Slashed Their ContextVision AB (publ) (OB:CONTX) Earnings Forecasts

There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings

Mar 04
There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings
User avatar

Future Investments In POCUS And Asian Expansion Will Strengthen Market Presence

Expansion into Asian markets and integration with new customers will boost revenues via enhanced customer base and market presence.

Subdued Growth No Barrier To ContextVision AB (publ) (OB:CONTX) With Shares Advancing 25%

Feb 25
Subdued Growth No Barrier To ContextVision AB (publ) (OB:CONTX) With Shares Advancing 25%

Is Now An Opportune Moment To Examine ContextVision AB (publ) (OB:CONTX)?

Feb 15
Is Now An Opportune Moment To Examine ContextVision AB (publ) (OB:CONTX)?

There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings

Sep 02
There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings

ContextVision AB (publ)'s (OB:CONTX) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Mar 11
ContextVision AB (publ)'s (OB:CONTX) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

ContextVision's (OB:CONTX) Soft Earnings Are Actually Better Than They Appear

Feb 22
ContextVision's (OB:CONTX) Soft Earnings Are Actually Better Than They Appear

ContextVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18
ContextVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Earnings Not Telling The Story For ContextVision AB (publ) (OB:CONTX)

Jan 26
Earnings Not Telling The Story For ContextVision AB (publ) (OB:CONTX)

When Should You Buy ContextVision AB (publ) (OB:CONTX)?

Jun 22
When Should You Buy ContextVision AB (publ) (OB:CONTX)?

Kazanç ve Gelir Büyüme Tahminleri

OB:CONTX - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SEK Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20281181616231
12/31/20271161212191
12/31/2026113810161
12/31/2025111104N/A
9/30/2025109429N/A
6/30/20251169614N/A
3/31/2025120131926N/A
12/31/2024131252933N/A
9/30/2024135223030N/A
6/30/2024138263536N/A
3/31/2024138334243N/A
12/31/2023133334445N/A
9/30/2023135374044N/A
6/30/2023130364043N/A
3/31/2023128363640N/A
12/31/2022123332126N/A
9/30/2022117341825N/A
6/30/202211537915N/A
3/31/202210635-42N/A
12/31/20211003559N/A
9/30/2021945388N/A
6/30/202190421011N/A
3/31/202186351823N/A
12/31/202095381422N/A
9/30/20209981123N/A
6/30/202010010926N/A
3/31/202010313020N/A
12/31/2019957225N/A
9/30/20199514N/A22N/A
6/30/20199411N/A24N/A
3/31/2019935N/A11N/A
12/31/201891-1N/A5N/A
9/30/201885-2N/A5N/A
6/30/201882-3N/A5N/A
3/31/201882-2N/A4N/A
12/31/201781-2N/A2N/A
9/30/201783-1N/A5N/A
6/30/2017851N/A1N/A
3/31/2017810N/A4N/A
12/31/2016824N/A10N/A
9/30/2016763N/A6N/A
6/30/2016734N/A10N/A
3/31/2016725N/A12N/A
12/31/2015725N/A9N/A
9/30/2015705N/A9N/A
6/30/2015674N/A10N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CONTX 'nin tahmini kazanç büyümesi (yıllık 55% ) tasarruf oranının ( 3.1% ) üzerindedir.

Kazançlar ve Piyasa: CONTX şirketinin kazançlarının (yıllık 55% ) Norwegian pazarından (yıllık 11% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: CONTX şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: CONTX şirketinin gelirinin (yıllık 2% ) Norwegian pazarından (yıllık 2.5% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: CONTX şirketinin gelirinin (yıllık 2% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CONTX 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 11.9 %).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/04 18:42
Gün Sonu Hisse Fiyatı2026/05/04 00:00
Kazançlar2025/12/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

ContextVision AB (publ) 3 Bu analistlerden 1, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Juste SubataviciuteNorne Securities AS
Christian LeePareto Securities
Klas PalinRedeye